Skip to main content

Table 1 The correlation of the level of TUBA1C expression with the clinical features of lung adenocarcinoma

From: Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma

Characteristics TUBA1C (%) p‐value
Low High
n 149 241  
Age (years)    0.287
 ≤ 60 53 (35.6) 99 (41.1)
 > 60 96 (64.4) 142 (58.9)  
Sex    0.452
 Female 60 (40.3) 87 (36.1)
 Male 89 (59.7) 154 (63.9)  
Smoke    0.511
 No 123 (82.6) 192 (79.7)
 Yes 26 (17.4) 49 (20.3)  
Size    0.093
 ≤ 3 cm 92 (61.7) 127 (52.9)
 > 3 cm 57 (38.3) 113 (47.1)  
Histologic subtype    0.454
 Lepidic 2 (1.3) 10 (4.1)
 Acinar 59 (39.6) 100 (41.5)  
 Papillary 13 (8.7) 22 (9.1)  
 Micropapillary 3 (2.0) 8 (3.3)  
 Solid 72 (48.3) 101 (41.9)  
Lymph node metastasis    0.754
 No 83 (55.7) 130 (53.9)
 Yes 66 (44.3) 111 (46.1)
TNM    1
 I + II 107 (71.8) 174 (72.2)
 III + IV 42 (28.2) 67 (27.8)  
VPI    0.758
 No 131 (87.9) 209 (86.7)
 Yes 18 (12.1) 32 (13.3)